|
Market Cap (16-Jul) $5,430,596,608 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (26-May) 50,730,266 (14.95%) (3rd) |
|
52w High $25.41 |
52w Low $8.26 |
P/E 2,500.00 |
EPS -0.03 |
A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around , on 5 January 2024 at 11:08am.
Australian shares shrug off Wall Street losses to push higher. Telix Pharmaceuticals mulls Nasdaq listing. BlueBet jumps on merger talks. Follow updates here.
Read ArticleTLX was $11.22 at the close of trade on 30 June 2023
| Recent Articles about ASX:TLX | |
|---|---|
| 4-Jul | Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement
company-announcements.afr.com |
| 3-Jul | 604 Page 1 of 6 - Market Index
company-announcements.afr.com |
| 3-Jul | Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain ...
company-announcements.afr.com |
| 2-Jul | FDA Alignment to Advance ProstACT Global Phase 3 Trial - AFR
company-announcements.afr.com |
| 1-Jul | Notice of change of interests of substantial holder - AFR
company-announcements.afr.com |
| 23-Jun | Notice of ceasing to be a substantial holder - AFR
company-announcements.afr.com |
| 19-Jun | _Annual Report 2026 - Whitefield Group
company-announcements.afr.com |
| 16-Jun | Appendix 3Y Change in Director Interest - C Behrenbruch
company-announcements.afr.com |
| 16-Jun | Appendix 3Y Change in Director Interest - Maria Rivas - 01 Jun 2026
company-announcements.afr.com |
| 16-Jun | Becoming a substantial holder - ASX Announcement - Market Index
company-announcements.afr.com |
| Tracked |
Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
Telix Pharmaceuticals 